SKSomaye Karimi

Somaye Karimi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Somaye Karimi has a total of 10 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A review on the process immune system's interaction with mycobiota and pathogenic fungi

    by Mitra Rafiee, Somaye Karimi, Mohammad Amin Abdolahi Ziaaldini, Fatemeh Nikoomanesh

    In recent years, the role of mycobiota as a fungal component of the human microbiota and its complex interactions with the immune system have become a major focus of immunology and infectious disease research. Increasing evidence suggests that mycobiota, in addition to maintaining mucosal homeostasis, plays a fundamental role in inducing immune tolerance, ...

  • Open Access

    Thymoquinone Inhibits Proliferation and Induces Apoptosis in Immortalized Keratinocytes via Upregulation of p53 Expression

    by Somaye Karimi, Narges Fallahi, Seyedeh Sindokht Hosseini, Mohammad Fereidouni, Fahime Ghasemi, Atena Mansouri, Nafiseh Erfanian, Mehdi Shakibaie, Mitra Rafiee

    Introduction: Psoriasis, as a common inflammatory skin disease, is characterized by hyperproliferation of epidermal keratinocytes and induction of an inflammatory response. Apoptosis induction and prevention of the proliferation of keratinocytes can help to treat and manage this disease. Thymoquinone (TQ), a bioactive compound with antioxidant and anti‐inflammatory properties, has also been reported as a natural antitumor agent. This study aimed to evaluate the effects of TQ on proliferation and apoptosis in human keratinocyte cells (HaCaT). Methods: HaCaT cells were treated with increasing concentrations of TQ (1, 2, 4, 6, 8, 16, 32, and 64 μg/mL), and cell viability was assessed using the MTT assay. Apoptosis was analyzed via flow cytometry using Annexin V‐FITC/PI staining. Expression levels of p53, Bax, and BCL‐xl genes were measured by real‐time PCR. Results: TQ significantly reduced cell viability in a dose‐dependent manner, with an IC50 of 11.64 μg/mL after 72 h. Flow cytometry revealed a marked increase in early apoptotic cells following treatment with 8 μg/mL TQ (41.00% ± 5.04%) compared to control (17.8% ± 2.26%, P ≤ 0.001). Gene expression analysis showed significant upregulation of p53, while Bax and BCL‐xl levels showed no significant changes. Conclusion: TQ induces apoptosis in human HaCaT cells primarily through p53‐dependent pathways, suggesting its potential as a therapeutic agent for skin‐related disorders .